BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19950259)

  • 1. The FAS -670A>G polymorphism influences susceptibility to systemic sclerosis phenotypes.
    Broen J; Gourh P; Rueda B; Coenen M; Mayes M; Martin J; Arnett FC; Radstake TR;
    Arthritis Rheum; 2009 Dec; 60(12):3815-20. PubMed ID: 19950259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis.
    Liakouli V; Manetti M; Pacini A; Tolusso B; Fatini C; Toscano A; Cipriani P; Guiducci S; Bazzichi L; Codullo V; Ruocco L; Dell'orso L; Carubbi F; Marrelli A; Abbate R; Bombardieri S; Ferraccioli G; Montecucco C; Valentini G; Matucci-Cerinic M; Ibba-Manneschi L; Giacomelli R
    Ann Rheum Dis; 2009 Apr; 68(4):584-90. PubMed ID: 18445624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of polymorphisms in the IL1B and IL2 genes with susceptibility and severity of systemic sclerosis.
    Mattuzzi S; Barbi S; Carletto A; Ravagnani V; Moore PS; Bambara LM; Scarpa A
    J Rheumatol; 2007 May; 34(5):997-1004. PubMed ID: 17444587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype.
    Rueda B; Broen J; Simeon C; Hesselstrand R; Diaz B; Suárez H; Ortego-Centeno N; Riemekasten G; Fonollosa V; Vonk MC; van den Hoogen FH; Sanchez-Román J; Aguirre-Zamorano MA; García-Portales R; Pros A; Camps MT; Gonzalez-Gay MA; Coenen MJ; Airo P; Beretta L; Scorza R; van Laar J; Gonzalez-Escribano MF; Nelson JL; Radstake TR; Martin J
    Hum Mol Genet; 2009 Jun; 18(11):2071-7. PubMed ID: 19286670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the PTPN22 R620W polymorphism with anti-topoisomerase I- and anticentromere antibody-positive systemic sclerosis.
    Gourh P; Tan FK; Assassi S; Ahn CW; McNearney TA; Fischbach M; Arnett FC; Mayes MD
    Arthritis Rheum; 2006 Dec; 54(12):3945-53. PubMed ID: 17133608
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Zmorzyński S; Wojcierowska-Litwin M; Kowal M; Michalska-Jakubus M; Styk W; Filip AA; Walecka I; Krasowska D
    Biomed Res Int; 2020; 2020():8465971. PubMed ID: 32185220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A large multicentre analysis of CTGF -945 promoter polymorphism does not confirm association with systemic sclerosis susceptibility or phenotype.
    Rueda B; Simeon C; Hesselstrand R; Herrick A; Worthington J; Ortego-Centeno N; Riemekasten G; Fonollosa V; Vonk MC; van den Hoogen FH; Sanchez-Román J; Aguirre-Zamorano MA; García-Portales R; Pros A; Camps MT; Gonzalez-Gay MA; Gonzalez-Escribano MF; Coenen MJ; Lambert N; Nelson JL; Radstake TR; Martin J
    Ann Rheum Dis; 2009 Oct; 68(10):1618-20. PubMed ID: 19054816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of TAP1 and TAP2 gene polymorphisms with systemic sclerosis in Korean patients.
    Song YW; Lee EB; Whang DH; Kang SJ; Takeuchi F; Park MH
    Hum Immunol; 2005 Jul; 66(7):810-7. PubMed ID: 16112028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a shared autoimmune disease-associated polymorphism of TRAF6 in systemic sclerosis and giant cell arteritis.
    Carmona FD; Serrano A; Rodríguez-Rodríguez L; Callejas JL; Simeón CP; Carreira P; Castañeda S; Solans R; Blanco R; ; ; González-Gay MA; Martín J
    J Rheumatol; 2012 Jun; 39(6):1275-9. PubMed ID: 22589256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BANK1 functional variants are associated with susceptibility to diffuse systemic sclerosis in Caucasians.
    Rueda B; Gourh P; Broen J; Agarwal SK; Simeon C; Ortego-Centeno N; Vonk MC; Coenen M; Riemekasten G; Hunzelmann N; Hesselstrand R; Tan FK; Reveille JD; Assassi S; Garcia-Hernandez FJ; Carreira P; Camps M; Fernandez-Nebro A; Garcia de la Peña P; Nearney T; Hilda D; Gónzalez-Gay MA; Airo P; Beretta L; Scorza R; Radstake TR; Mayes MD; Arnett FC; Martin J
    Ann Rheum Dis; 2010 Apr; 69(4):700-5. PubMed ID: 19815934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic Risk Score impact on susceptibility to systemic sclerosis.
    Bossini-Castillo L; Villanueva-Martin G; Kerick M; Acosta-Herrera M; López-Isac E; Simeón CP; Ortego-Centeno N; Assassi S; ; ; ; ; Hunzelmann N; Gabrielli A; de Vries-Bouwstra JK; Allanore Y; Fonseca C; Denton CP; Radstake TR; Alarcón-Riquelme ME; Beretta L; Mayes MD; Martin J
    Ann Rheum Dis; 2021 Jan; 80(1):118-127. PubMed ID: 33004331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional variants of Fc gamma receptor (FCGR2A) and FCGR3A are not associated with susceptibility to systemic sclerosis in a large European Study (EUSTAR).
    Alizadeh BZ; Broen J; Rueda B; Hesselstrand R; Wuttge D; Simeon C; Ortego-Centeno N; Gonzalez-Gay MA; Pros A; Herrick A; Worthington J; Denton C; Fonseca C; Riemekasten G; Vonk MC; van den Hoogen F; Guiducci S; Matucci-Cerinic M; Scorza R; Beretta L; Airó P; Coenen M; Martin J; Koeleman BP; Radstake TR;
    J Rheumatol; 2010 Aug; 37(8):1673-9. PubMed ID: 20551103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An MIF Promoter Polymorphism Is Associated with Susceptibility to Pulmonary Arterial Hypertension in Diffuse Cutaneous Systemic Sclerosis.
    Bossini-Castillo L; Campillo-Davó D; López-Isac E; Carmona FD; Simeon CP; Carreira P; Callejas-Rubio JL; Castellví I; Fernández-Nebro A; Rodríguez-Rodríguez L; Rubio-Rivas M; García-Hernández FJ; Madroñero AB; Beretta L; Santaniello A; Lunardi C; Airó P; Hoffmann-Vold AM; Kreuter A; Riemekasten G; Witte T; Hunzelmann N; Vonk MC; Voskuyl AE; de Vries-Bouwstra J; Shiels P; Herrick A; Worthington J; Radstake TRDJ; Martin J;
    J Rheumatol; 2017 Oct; 44(10):1453-1457. PubMed ID: 28668810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility.
    Diaz-Gallo LM; Simeon CP; Broen JC; Ortego-Centeno N; Beretta L; Vonk MC; Carreira PE; Vargas S; Román-Ivorra JA; González-Gay MA; Tolosa C; López-Longo FJ; Espinosa G; Vicente EF; Hesselstrand R; Riemekasten G; Witte T; Distler JH; Voskuyl AE; Schuerwegh AJ; Shiels PG; Nordin A; Padyukov L; Hoffmann-Vold AM; Scorza R; Lunardi C; Airo P; van Laar JM; Hunzelmann N; Gathof BS; Kreuter A; Herrick A; Worthington J; Denton CP; Zhou X; Arnett FC; Fonseca C; Koeleman BP; Assasi S; Radstake TR; Mayes MD; Martín J;
    Ann Rheum Dis; 2013 Jul; 72(7):1233-8. PubMed ID: 23172754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of FAS gene variants in inflammatory bowel disease.
    Demir A; Kahraman R; Candan G; Ergen A
    Turk J Gastroenterol; 2020 May; 31(5):356-361. PubMed ID: 32519954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis.
    Diaz-Gallo LM; Gourh P; Broen J; Simeon C; Fonollosa V; Ortego-Centeno N; Agarwal S; Vonk MC; Coenen M; Riemekasten G; Hunzelmann N; Hesselstrand R; Tan FK; Reveille JD; Assassi S; García-Hernandez FJ; Carreira P; Camps MT; Fernandez-Nebro A; de la Peña PG; Nearney T; Hilda D; González-Gay MA; Airo P; Beretta L; Scorza R; Herrick A; Worthington J; Pros A; Gómez-Gracia I; Trapiella L; Espinosa G; Castellvi I; Witte T; de Keyser F; Vanthuyne M; Mayes MD; Radstake TR; Arnett FC; Martin J; Rueda B
    Ann Rheum Dis; 2011 Mar; 70(3):454-62. PubMed ID: 21131644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FAS -670A>G genetic polymorphism Is associated with Treatment Resistant Depression.
    Santos M; Carvalho S; Lima L; Mota-Pereira J; Pimentel P; Maia D; Correia D; Gomes S; Cruz A; Medeiros R
    J Affect Disord; 2015 Oct; 185():164-9. PubMed ID: 26186532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TCRBV20S1 and TCRBV3S1 gene segment polymorphisms in systemic sclerosis.
    Bredemeier M; Chies JA; Wieck A; Capobianco KG; Pitrez EH; Rohde LE; Pinotti AF; Brenol JC; Xavier RM
    J Rheumatol; 2008 Jun; 35(6):1058-63. PubMed ID: 18412309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between FAS gene -670 A/G and -1377 G/A polymorphisms and the risk of autoimmune diseases: a meta-analysis.
    Yan H; Hong Y; Cai Y
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31840751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis.
    Sobanski V; Giovannelli J; Allanore Y; Riemekasten G; Airò P; Vettori S; Cozzi F; Distler O; Matucci-Cerinic M; Denton C; Launay D; Hachulla E;
    Arthritis Rheumatol; 2019 Sep; 71(9):1553-1570. PubMed ID: 30969034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.